(Q38310416)

English

The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: a systematic review and critical appraisal

scientific article published on March 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

1 reference

Europe PubMed Central

The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: a systematic review and critical appraisal (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

systematic review

1 reference

based on heuristic

inferred from title

pancreatic cancer

1 reference

based on heuristic

inferred from title

Hanneke Wm van Laarhoven

2

object named as

Hanneke W M van Laarhoven

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

author name string

Maarten F Bijlsma

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Cancer and Metastasis Reviews

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

97-114

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Pancreatic cancer genomics: insights and opportunities for clinical translation

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Molecular classification of neoplasms of the pancreas

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Integrative survival-based molecular profiling of human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

The impact of the activated stroma on pancreatic ductal adenocarcinoma biology and therapy resistance

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Normalization of the vasculature for treatment of cancer and other diseases

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Hypoxia and radiation therapy: past history, ongoing research, and future promise

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Pancreatic cancer microenvironment

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Molecular regulation of pancreatic stellate cell function

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Cancer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Bone marrow-derived pancreatic stellate cells in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Role of bone marrow cells in the development of pancreatic fibrosis in a rat model of pancreatitis induced by a choline-deficient/ethionine-supplemented diet

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Recruitment and activation of pancreatic stellate cells from the bone marrow in pancreatic cancer: a model of tumor-host interaction

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Microenvironmental regulation of stem cells in intestinal homeostasis and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Cancer heterogeneity--a multifaceted view

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Nuclear translocation of FGFR1 and FGF2 in pancreatic stellate cells facilitates pancreatic cancer cell invasion

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Cyclopamine and hedgehog signaling: chemistry, biology, medical perspectives

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Two critical periods of Sonic Hedgehog signaling required for the specification of motor neuron identity

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Sonic hedgehog promotes desmoplasia in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Hedgehog promotes neovascularization in pancreatic cancers by regulating Ang-1 and IGF-1 expression in bone-marrow derived pro-angiogenic cells

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

A novel synthetic smoothened antagonist transiently inhibits pancreatic adenocarcinoma xenografts in a mouse model

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Pancreatic stellate cells form a niche for cancer stem cells and promote their self-renewal and invasiveness.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Evaluation of the Metabolic Response to Cyclopamine Therapy in Pancreatic Cancer Xenografts Using a Clinical PET-CT System

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Tumor-stroma interaction in orthotopic primary pancreatic cancer xenografts during hedgehog pathway inhibition

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Stromal disrupting effects of nab-paclitaxel in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Overcoming the stromal barrier for targeted delivery of HPMA copolymers to pancreatic tumors

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Inhibitory effect of 4-methylesculetin on hyaluronan synthesis slows the development of human pancreatic cancer in vitro and in nude mice

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Involvement of host stroma cells and tissue fibrosis in pancreatic tumor development in transgenic mice

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-beta signaling.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

The angiotensin II type I receptor blocker olmesartan inhibits the growth of pancreatic cancer by targeting stellate cell activities in mice

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Diclofenac Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer by Modulation of VEGF Levels and Arginase Activity

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Stromal response to Hedgehog signaling restrains pancreatic cancer progression

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Assessment of the stromal contribution to Sonic Hedgehog-dependent pancreatic adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

High-throughput live-cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Transforming growth factor-beta: what every pancreatic surgeon should know

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

A compendium of potential biomarkers of pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Mouse models of advanced spontaneous metastasis for experimental therapeutics

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9541-1

21 January 2018

Identifiers

10.1007/S10555-014-9541-1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38310416&oldid=2246618123"